Home › Funds › Inspire Investing, LLC › IBD

Inspire Investing, LLC position in IBD

INSPIRE CORPORATE BOND ETF

Inspire Investing, LLC reported holding 838,148 shares of IBD (INSPIRE CORPORATE BOND ETF) in its Q3 2026 13F filing — a position valued at US$19.3M, representing 0.81% of its reported portfolio and ranking #13 among its reported holdings. Inspire Investing, LLC has disclosed IBD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)838.15K sh
Reported value held$19.28M
Portfolio Weight0.81%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Inspire Investing, LLC's IBD position evolved

Inspire Investing, LLC first disclosed a stake in IBD in Q3 2023 at 1,038,728 shares (US$23.5M). The position peaked in Q1 2026 at 988,722 shares, worth US$23.6M. Across 13 filings, Inspire Investing, LLC increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 838,148 shares valued at US$19.3M — an increase of 69,554 shares quarter over quarter.. Notable position changes include a 39% trim in Q4 2023 (shares were roughly flat over the following quarter), a 59% increase in Q2 2024 (shares rose 3% over the following quarter), a 35% increase in Q1 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.04M $23.52M New
Q4 2023 632.56K $14.92M Reduce
Q1 2024 622.48K $14.62M Reduce
Q2 2024 991.21K $23.11M Add
Q3 2024 830.38K $20.00M Reduce
Q4 2024 549.23K $12.87M Reduce
Q1 2025 584.72K $13.89M Add
Q2 2025 598.05K $14.36M Add
Q3 2025 661.40K $15.97M Add
Q4 2025 732.65K $17.73M Add
Q1 2026 988.72K $23.59M Add
Q2 2026 768.59K $18.27M Reduce
Q3 2026 838.15K $19.28M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IBD and 13F data

IBD (INSPIRE CORPORATE BOND ETF) is a company whose sector is not yet classified in our data. 30 other funds we track also report a position in IBD — the largest reported positions include Inspire Advisors, LLC (US$97.5M), Faithward Advisors, LLC (US$40.8M), CREATIVE FINANCIAL DESIGNS INC /ADV (US$22.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IBD

All IBD fund holders →

FAQ

How long has Inspire Investing, LLC held IBD?

Inspire Investing, LLC has disclosed IBD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Inspire Investing, LLC's current position in IBD?

As of Q3 2026, Inspire Investing, LLC holds 838.15K shares of IBD (INSPIRE CORPORATE BOND ETF), valued at $19.28M, representing 0.81% of its reported portfolio and ranking #13.

Has Inspire Investing, LLC been buying or selling IBD?

In the latest 13F filing (Q3 2026), Inspire Investing, LLC increased its position in IBD. The position peaked in Q1 2026 at 988.72K shares.

Which other funds hold IBD?

Other major institutional holders of IBD include Inspire Advisors, LLC, Faithward Advisors, LLC, CREATIVE FINANCIAL DESIGNS INC /ADV, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.